Prostate Cancer Symptoms Tips What is prostate cancer symptoms? We have tips about prostate cancer symptoms

Join the Abramson Cancer Center and Caring for Carcinoid Friday, November 2 for a free conference about neuroendocrine tumors.

Neuroendocrine tumors (NETs) form from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, phechromocytomas and Merkel cell cancers.

Neuroendocrine tumors are often small and can be malignant (cancerous) or benign (non-cancerous).

Patients with NETs are treated at Penn by a multidisciplinary team of cancer specialists who see more patients with gastrointestinal (GI) cancers in one year than many doctors see in their careers.

In addition, the Neuroendocrine Tumor Center at Penn offers patients:

• A tumor board: A treatment planning approach in which the NET team reviews and discusses the medical condition and treatment options of a patient.
• Nurse navigators: Specialty nurses available to guide patients through the appointment and treatment process.
• A single point of contact.

Who Should Attend the NET Conference?

The Focus On Neuroendocrine Tumors conference is for people who are newly diagnosed, currently in treatment or long-term survivor of:

Gastrointestinal Tract NETs including:

• Pancreatic NETs (hereditary or sporadic)
• Zollinger-Ellison syndrome (gastrinomas)
• Insulinomas
• Alimentary tract NETs (foregut, midgut or hindgut)
• Functional (carcinoid syndrome)
• Non-functional

Pheochromocytomas and Paragangliomas including hereditary and sporadic forms
Bronchial and Thymic Carcinoids
Hereditary Syndromes including:

• Multiple Endocrine Neoplasia (MEN)
• Neurofibromatosis type 1 (NF1)
• von Hippel–Lindau (VHL)
• SDHB and SDHD mutations

Register for the Focus On Neuroendocrine Tumors Conference

The Focus on NET Conference is free, and open to the public.

Date: Friday, November 2, 2012
Time: 7:30 am to 3:15 pm
Location: Hilton Hotel, 4200 City Line Avenue, Philadelphia, PA
Registration: Register here for the conference

Can’t Attend In Person?

If you can’t attend in person, view the Livestream of the event, at PennMedicine.org/Abramson/NETsLIVE , follow @PennMedicine on Twitter with the hashtag #NETsACC, or join Oncolink from 12:30 to 1:30 pm for a Webchat about NETs. 

David C. Metz, MD

 
That is why it is my absolute pleasure to inform you of Penn Medicine’s Neuroendocrine Tumor (NET) Symposium, a CME-certified course*, scheduled for Friday, Sept. 9 on the Penn campus. 

Penn Medicine’s NET program has been designed to provide excellent state-of-the-art diagnosis and management of patients with gastrointestinal NETs, including alimentary tract carcinoids or pancreatic NETs, as well as pheochromocytomas and paragangliomas.

• Arise in multiple different primary sites.
• Be functional or non functional (functional syndromes also vary significantly between patients).
• Have variable biological behavior which is difficult to predict.

Many tumors also arise as a component of an inherited syndrome such as MEN-1 or 2 or one of the phacomatoses (neurocutaneous syndromes).  The management of localized disease is primarily surgical, but commonly patients present with metastases requiring a multidisciplinary approach for effective long-term management.

This CME course has been designed to demonstrate the broad expertise available at Penn Medicine as well as to provide in-depth lectures on all the various disciplines involved in the management of NET patients.   This will be an excellent learning experience for physicians, extenders, nurses and trainees.  We hope to provide a general algorithm for the management of these often complex and difficult to treat and diagnosis patients.  Hopefully, you will be able to join us.

Where: Biomedical Research Building II/III, 421 Curie Boulevard, Philadelphia, PA


* Accreditation:  The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.